Tag: CBT > CBD DEA: Page 2

Adult-Use Legalization Bill

Congressional Committee Hearing Navigates the Catch-22 of Cannabis Research

The far-reaching committee hearing was convened to discuss six cannabis reform proposals currently undergoing congressional consideration.

January 17, 2020

Legislation and Regulation

Akers Bio Forms Advisory Board to Explore Involvement in the Hemp and Minor Cannabinoid Market

Recent FDA statements on the danger of CBD products in the open market and the need for DEA-regulated testing have given companies like Akers Bio an opportunity to explore a role in hemp and minor cannabinoid testing and processing.

December 6, 2019

Finance

Bragar Eagel & Squire, P.C. Is Investigating Curaleaf Holdings, Inc. on Behalf of Stockholders, Encourages Investors to Contact the Firm

The investigation concerns whether Curaleaf has violated the federal securities laws and/or engaged in other unlawful business practices.

August 2, 2019